TrialPloS one2015

Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patients.

Yang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.